Prevalence of Schizophrenia Spectrum and Bipolar Disorder Among Cannabis Induced Psychosis Patients
Cannabis induced psychosis risk is a critical clinical concern with significant implications for patient prognosis. This review provides prevalence data on progression to schizophrenia spectrum and bipolar disorder. Understanding this risk helps guide…
Cannabinoid Clinical Trials: Cannabis-Induced Psychosis Risk
Clinical trials reveal that cannabis-induced psychosis risk is significant for developing schizophrenia spectrum and bipolar disorders. This risk underscores the importance of long-term psychiatric follow-up. Early monitoring after cannabis-induced…
Endocannabinoid System & Cannabis-Induced Psychosis Research
Cannabis-induced psychosis schizophrenia risk is a critical concern for clinicians. A significant portion of patients with cannabis-induced psychosis later develop schizophrenia spectrum or bipolar disorder. Early identification and structured follow-up…
Teenage Cannabis Users Twice as Likely as Non-Users to Develop Psychosis
A landmark study highlights teen cannabis psychosis risk, showing adolescents who use cannabis have twice the chance of developing psychotic disorders. This research tracked over 460,000 teens and found cannabis use preceded psychiatric diagnoses by up…
Satiety Bypass: How Cannabis Overrides the Brain’s ‘I’m Full’ Signal
Cannabis-induced appetite occurs when THC activates CB1 receptors in the hypothalamus, overriding natural satiety signals. This mechanism creates a feeling of starvation even after eating. Understanding cannabis-induced appetite is key for developing…